Saisei Ventures

Type

Venture Capital

Status

Active

Location

Cambridge, United States

Total investments

6

Average round size

19M

Portfolio companies

4

Rounds per year

1.50

Follow on index

0.33

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceMachine LearningHealth CareHealth DiagnosticsMedicalNutritionNursing and Residential Care

Investor highlights

Industry focus
Biotech/Life SciencesManufacturingMedtechAI/Big Data
Stage focus
Series BSeedSeries A
Geo focus
Japan

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
6
Lead investments
0
Rounds per year
1.50
Follow on index
0.33
Investments by industry
  • Health Care (6)
  • Medical (4)
  • Biotechnology (2)
  • Nutrition (2)
  • Nursing and Residential Care (2)
  • Show 3 more
Investments by region
  • United States (2)
  • Japan (4)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
0.83

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ryne Biotechnology 29 Feb 2024 Biotechnology, Health Care, Medical Early Stage Venture 82M United States, Massachusetts, Cambridge
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.